{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "exchange": "KOE", "shortName": "CrystalGenomics", "longName": "CrystalGenomics, Inc.", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketChangePercent": 2.4271843, "regularMarketPrice": 3165.0, "marketState": "PREPRE", "fiftyTwoWeekHighChangePercent": -0.48284313, "fiftyTwoWeekLow": 2900.0, "fiftyTwoWeekHigh": 6120.0, "earningsTimestamp": 1677581940, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 40452700, "fiftyDayAverage": 3355.6, "fiftyDayAverageChange": -190.6001, "fiftyDayAverageChangePercent": -0.0568006, "twoHundredDayAverage": 3493.85, "twoHundredDayAverageChange": -328.8501, "twoHundredDayAverageChangePercent": -0.09412255, "marketCap": 128032792576, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 75.0, "regularMarketTime": 1683873010, "regularMarketDayHigh": 3205.0, "regularMarketDayRange": "3015.0 - 3205.0", "regularMarketDayLow": 3015.0, "regularMarketVolume": 202386, "regularMarketPreviousClose": 3090.0, "bid": 3160.0, "ask": 3170.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 3090.0, "averageDailyVolume3Month": 316736, "averageDailyVolume10Day": 139239, "fiftyTwoWeekLowChange": 265.0, "fiftyTwoWeekLowChangePercent": 0.09137931, "fiftyTwoWeekRange": "2900.0 - 6120.0", "fiftyTwoWeekHighChange": -2955.0, "firstTradeDateMilliseconds": 1136505600000, "symbol": "083790.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Tower A, Korea Bio Park", "address2": "5th Floor 694-1, Sampyeong-dong Bundang-gu", "city": "Seongnam-si", "zip": "463-400", "country": "South Korea", "phone": "82 3 1628 2700", "fax": "82 3 1628 2701", "website": "https://www.cgxinc.com", "industry": "", "sector": "", "longBusinessSummary": "CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joong-Myung  Cho Ph.D.", "age": 74, "title": "Chairman, Founder, CEO & Pres", "yearBorn": 1948, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Seonggu  Ro Ph.D.", "age": 62, "title": "Co-Founder, Chief Technology Officer, Exec. VP and Director", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sang-Cheon  Ahn", "age": 59, "title": "Exec. Managing Director and Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yong-Rae  Hong", "age": 54, "title": "Exec. MD & Research Head of Institute for Drug Discovery", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}